Public health impact of Rotarix vaccination among commercially insured children in the United States
Vaccine Aug 18, 2017
Krishnarajah G, et al. – This study outlined the public health impact of Rotarix, GSK [RV1] vaccination among commercially insured children in the United States. Evidence displayed that RV1 vaccination offered benefits in reduction of RV incidence, RV– and diarrhea–related healthcare resource utilization, and RV– and diarrhea–related healthcare costs.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
